ICRF has awarded more than $93 million in funding to support over 2,800 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
Ravid Straussman, MD, PhD Weizmann Institute of Science The ICRF – Mark Foundation for Cancer Research Project Grant BacterioOncology, Brain Cancer, Drug Resistance, Targeted Therapies Active
Yuval Tabach, PhD Hebrew University of Jerusalem Project Grant Animal Modes of Cancer Active
Itay Tirosh, PhD Weizmann Institute of Science Len & Susan Mark Initiative For Ovarian And Uterine/MMMT Cancers Grant Cancer Stem Cells, Computational Biology, Genetics and Genomics, Ovarian and Uterine Cancer Non-active
Amit Tirosh, MD Sheba Medical Center/ Tel Aviv University Clinical Research Career Development Award (CRCDA) Pancreatic Cancer Active
Israel Vlodavsky, PhD Technion, Israel Institute of Technology Research Professorship Grant Basic Research, Cancer Treatment, Clinical and Translational Research Non-active
Israel Vlodavsky, PhD Technion, Israel Institute of Technology Project Grant Breast Cancer, Cancer Treatment, Pancreatic Cancer Active
Reuven Wiener, PhD Hebrew University of Jerusalem Project Grant Drug Mechanisms and Development Active
Yosef Yarden, PhD Weizmann Institute of Science Len & Susan Mark Initiative For Ovarian And Uterine/MMMT Cancers Grant Immunology and Immunotherapy, Ovarian and Uterine Cancer Non-active
Yosef Yarden, PhD Weizmann Institute of Science Project Grant Drug Resistance, Experimental Therapeutics, Non-Small Cell Lung Cancer Active
Tal Yardeni, PhD Chaim Sheba Medical Center Research Career Development Award Immunology and Immunotherapy, Melanoma, Skin Cancer Active